1789 — ScinoPharm Taiwan Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for ScinoPharm Taiwan, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,132	4,346	3,942	4,166	3,110
Net Total Accounts Receivable
Net Total Receivables	393	654	813	654	624
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,967	6,320	6,381	6,608	5,491
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,883	4,797	4,578	4,576	4,228
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11,691	11,911	11,722	11,943	11,858
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	556	803	729	768	710
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,180	1,461	1,357	1,417	1,333
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	10,511	10,450	10,364	10,526	10,525
Total Liabilities & Shareholders' Equity	11,691	11,911	11,722	11,943	11,858
Total Common Shares Outstanding